AbbVie Inc at Barclays Global Healthcare Conference Transcript

Mar 13, 2019 / 02:15PM GMT
Geoffrey Christopher Meacham - Barclays Bank PLC, Research Division - MD & Senior Research Analyst

Okay. Welcome to the second day of the morning session of the Barclays Global Healthcare Conference. My name is Geoff Meacham. I'm the senior biopharma analyst here. So we're really excited to have AbbVie up on stage for a fireside chat. So we have Mike Severino, Vice Chairman and President; and Rob Michael, CFO. So welcome, guys.

Robert A. Michael - AbbVie Inc. - Senior VP & CFO

Thanks.

Michael E. Severino - AbbVie Inc. - Vice Chairman & President

Thanks.

Questions and Answers:

Geoffrey Christopher Meacham - Barclays Bank PLC, Research Division - MD & Senior Research Analyst

We'll kick it off with probably the more topical questions that we're getting from investors, mostly on just HUMIRA, biosimilars OUS. So maybe just give us a sense -- I know, over the course of last year, we got an update about the erosion curve. And kind of just help us, maybe at a
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot